The principles of long term management are inhibiting insulin secretion, thereby prevent recurrent hypoglycaemia episodes, provide an age appropriate fasting tolerance and avoid neurological symptoms associated to hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.